MAPS is answering questions during a IAMA about psychedelic research on Reddit

[greengummybear]

We are the Multidisciplinary Association for Psychedelic Studies (MAPS), and we are here to educate the public about research into the risks and benefits of psychedelics and marijuana. MAPS is a 501(c)(3) non-profit research and educational organization founded in 1986 that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

We envision a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.

Some of the topics we're passionate about include;

Research into the therapeutic potential of MDMA, LSD, psilocybin, ayahuasca, ibogaine, and marijuana
Integrating psychedelics and marijuana into science, medicine, therapy, culture, spirituality, and policy
Providing harm reduction and education services at large-scale events to help reduce the risks associated with the non-medical use of various drugs
Ways to communicate with friends, family, and the public about the risks and benefits of psychedelics and marijuana
Our vision for a post-prohibition world
Developing psychedelics and marijuana into prescription medicines through FDA-approved clinical research

List of participants:

Rick Doblin, Ph.D., Founder and Executive Director, MAPS
Brad Burge, Director of Communications and Marketing, MAPS
Amy Emerson, Executive Director and Director of Clinical Research, MAPS Public Benefit Corporation
Virginia Wright, Director of Development, MAPS
Brian Brown, Communications and Marketing Associate, MAPS
Sara Gael, Harm Reduction Coordinator, MAPS
Natalie Lyla Ginsberg, Research and Advocacy Coordinator, MAPS
Tess Goodwin, Development Assistant, MAPS
Ilsa Jerome, Ph.D., Research and Information Specialist, MAPS Public Benefit Corporation
Bryce Montgomery, Web and Multimedia Associate, MAPS
Shannon Clare Petitt, Executive Assistant, MAPS
Linnae Ponté, Director of Harm Reduction, MAPS
Ben Shechet, Clinical Research Associate, MAPS Public Benefit Corporation
Allison Wilens, Clinical Study Assistant, MAPS Public Benefit Corporation
Berra Yazar-Klosinski, Ph.D., Clinical Research Scientist, MAPS

For more information about scientific research into the medical potential of psychedelics and marijuana, visit maps.org.

You can support our research and mission by making a donation, signing up for our monthly email newsletter, or following us on Facebook, Twitter, and YouTube.

Ask us anything!

https://www.reddit.com/r/IAmA/comments/2vju7x/we_are_the_multidisciplinary_association_for/

 

[greengummybear]

* GreenGummyBear, who posted this link, is independent of MAPS.